Journal of obstetrics and women's diseasesJournal of obstetrics and women's diseases1684-04611683-9366Eco-Vector10142510.17816/JOWD101425Conference Report, Theses of ReportThe level of CA 125 antigen in serum from women with uterine myomaShevchukovaN. F.info@eco-vector.comKramarevaN. L.info@eco-vector.comKashcheyevaT. K.info@eco-vector.comD.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences15121999485S1451452202202222022022Copyright © 1999, Eсо-Vector1999<p><strong>Objective: </strong>The literature data on the prognostic role of blood CA 125 concentration in the patients with uterine myoma are rather different.</p>CA 125 antigenuterine myomamyoma necrosisendometrial hyperplasiaintrauterine contraception<p><strong>Objective: </strong>The literature data on the prognostic role of blood CA 125 concentration in the patients with uterine myoma are rather different.</p>
<p><strong>Methods</strong>: CA 125 concentration was determined in serum samples from cubital vena and uterine vena respectively from 50 and 28 patients with uterine myoma. In the range of 0-1000 units, all assays tested correlated well with clinical findings (range of correlation coefficients 0.05 0.3)</p>
<p><strong>Results: </strong>The CA 125 concentrations were increased in all uterine vena serum samples and were increased only in 17% of cubital serum samples.</p>
<p><strong>Conclusion: </strong>We conclude that the increase of CA 125 serum level was associated with myoma necrosis, endometrial hyperplasia, intrauterine contraception usage for a long period. Moreover, the increase of CA 125 serum is an additional diagnostic test for determination of the type and time of operation.</p>